Alzeihmer Disease clinical trials

Explore recruiting alzeihmer disease clinical trials.

Also recruiting in Europe

Alzeihmer Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Impact of microglial activation on synaptic density in Alzheimer’s disease

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Therapeutic evaluation of low-dose IL-2-based immunomodulatory approach in patients with early AD

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Alzeihmer Disease trials by city

Alzeihmer Disease in Toronto Alzeihmer Disease in Vancouver Alzeihmer Disease in Montreal Alzeihmer Disease in Calgary Alzeihmer Disease in Edmonton Alzeihmer Disease in Ottawa Alzeihmer Disease in Winnipeg Alzeihmer Disease in Quebec City Alzeihmer Disease in Hamilton Alzeihmer Disease in Kitchener Alzeihmer Disease in London Alzeihmer Disease in Halifax Alzeihmer Disease in New York Alzeihmer Disease in Los Angeles Alzeihmer Disease in Chicago Alzeihmer Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease